Viewing Study NCT05814666


Ignite Creation Date: 2025-12-24 @ 4:05 PM
Ignite Modification Date: 2025-12-25 @ 2:06 PM
Study NCT ID: NCT05814666
Status: RECRUITING
Last Update Posted: 2024-12-31
First Post: 2023-03-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Sponsor: Flamingo Therapeutics NV
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module